RUZZO, ANNAMARIA
RUZZO, ANNAMARIA
Dipartimento di Scienze Biomolecolari (DISB)
2196 Polymorphisms and miRNAs targeting CLOCK gene affect gender-related survival in metastatic colorectal cancer (mCRC) patients (pts)
2015 Torsello, A.; Ruzzo, Annamaria; Sperduti, I.; Melucci, E.; Giacomini, E.; Mottolese, M.; Fiorino, R.; Zeuli, M.; Pescarmona, E.; Magnani, Mauro; Cognetti, F.; Garufi, C.
2206P Detection of circulating KRAS4A and KRAS4B isoforms in patients with metastatic lung adenocarcinoma treated with pembrolizumab or chemotherapy plus pembrolizumab by liquid biopsy: Clinical impact and association with circulating PD-L1
2023 Palladino, S.; Ruzzo, A.; Emili, R.; Catalano, V.; De Lisa, M.; Sarti, D.; Magnani, M.; Graziano, F.; Chiari, R.
[Construction of an apparatus for pulsed field electrophoresis for the analysisof high molecular weight DNA]
1989 Gennarelli, M; Novelli, G; Ruzzo, Annamaria; Grianti, F; Dallapiccola, B.
A novel diffuse gastric cancer susceptibility variant in E-caderin(CDH1) intron 2: A case control study in an Italian population
2008 Nasri, S; More, H; Graziano, F; Ruzzo, Annamaria; Wilson, E; Dunbier, A; Mckinney, C; Merriman, T; Guilford, P; Magnani, Mauro; Humar, B.
A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4
2020 Campopiano, Rosa; Ferese, Rosangela; Buttari, Fabio; Femiano, Cinzia; Centonze, Diego; Fornai, Francesco; Biagioni, Francesca; Chiaravalloti, Maria Antonietta; Magnani, Mauro; Giardina, Emiliano; Ruzzo, Anna; Gambardella, Stefano
A pharmacogenetic study for clinical outcomes of high-risk stage II and stage III colon cancer patients Treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy
2017 Ruzzo, Annamaria; Galli, Fabio; Galli, Francesca; Rulli, E; Bagaloni, Irene; Lonardi, S; Bergamo, F; Ronzoni, M; Ionta, Mt; Massidda, B; Pella, N; Mucciarini, C; Labianca, R; Veltri, E; Sozzi, P; Barni, S; Nicolini, M; Biondi, E; Bramati, A; Turci, D; Buscaglia, M; Magnani, Mauro; Graziano, F.
Amphiregulin (AR) expression in the prediction of benefit from cetuximab plus irinotecan in KRAS wild-type metastatic colorectal cancer (mCRC) patients
2009 Loupakis, F; Cremolini, C; Perrone, G; Stasi, I; Salvatore, L; Vincenzi, B; Ruzzo, Annamaria; Ronzoni, M; Bencardino, K; Falcone, A.
Amplificazione enzimatica specifica di una regione di DNA strettamente associata alla Corea di Huntington
1990 Novelli, G; Mandich, P; Ruzzo, Annamaria; Mannello, Ferdinando; Ajmar, F; Dallapiccola, B.
An erythroid-specific exon is present in the human hexokinase gene
1998 Ruzzo, Annamaria; Andreoni, Francesca; Magnani, Mauro
Analysis of polymorphisms in the Interleukin-1beta gene (IL-1B) and in the Interleukin-1 receptor anatagonist gene (IL-1RN) for gastric cancer susceptibility in Helicobacter Pylori (HP) negative, Italian patients. A report from the Italian Group for Genetic Research in Gastric Cancer (IGGRGC)
2004 Ruzzo, Annamaria; Pizzagalli, F; Graziano, F; Santini, D; Catalano, V; Scartozzi, M; Ficarelli, R; Bearzl, I; Cascinu, S; Magnani, Mauro
ANALYSIS OF PTEN EXPRESSION AND KRAS MUTATIONS ON PRIMARIES (PRIM) AND METASTASES (METS) TO PREDICT BENEFIT FROM CETUXIMAB PLUS IRINOTECAN (CETIRI) IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS)
2008 Loupakis, F; Pollina, L; Ruzzo, Annamaria; Masi, G; Cremolini, C; Scartozzi, M; Floriani, I; Santini, D; Cascinu, S; Falcone, A.
Assignment of the hexokinase type 3 gene (HK3) to human chromosome band 5q35.3 by somatic cell hybrids and in situ hybridization
1996 Colosimo, A; Calabrese, G; Gennarelli, M; Ruzzo, Annamaria; Sangiuolo, F; Magnani, Mauro; Palka, G; Novelli, G; Dallapiccola, B.
Association of BRAF mutations and EGFR Intron-1 L/L genotype with resistance to cetuximab plus irinotecan treatment in KRAS wild-type metastatic colorectal cancer patients
2009 Ruzzo, Annamaria; Cremolini, C; Loupakis, F; Fornaro, L; Santini, D; Vincenzi, B; Canestrari, E; Magnani, Mauro; Falcone, A; Graziano, F.
Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer
2002 Humar, B; Graziano, F; Cascinu, S; Catalano, V; Ruzzo, Annamaria; Magnani, Mauro; Toro, T; Burchill, T; Futschik, Me; Merriman, T; Guilford, P.
Association of Thymidylate Synthase Polymorphisms with Gastric Cancer Susceptibility
2004 Graziano, F; Kawakami, K; Watanabe, G; Ruzzo, Annamaria; Humar, B; Santini, D; Catalano, V; Ficarelli, R; Merriman, T; Panunzi, S; Testa, E; Cascinu, S; Bearzi, I; Tonini, G; Magnani, Mauro
ASSOCIATION OF THYMIDYLATHE SYNTHASE POLYMORPHISMS WITH GASTRIC CANCER SUSCEPTIBILITY
2004 Graziano, F; Kawakami, K; Watanabe, G; Ruzzo, Annamaria; Santini, D; Catalano, V; Ficarelli, R; Humar, B; Merriman, T; Guilford, P; Testa, E; Galizia, E; Magnani, Mauro; Cascinu, S.
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
2020 Ruzzo, Annamaria; Graziano, Francesco; Galli, Francesca; Galli, Fabio; Rulli, Eliana; Lonardi, Sara; Ronzoni, Monica; Massidda, Bruno; Zagonel, Vittorina; Pella, Nicoletta; Mucciarini, Claudia; Labianca, Roberto; Teresa Ionta, Maria; Bagaloni, Irene; Veltri, Enzo; Sozzi, Pietro; Barni, Sandro; Ricci, Vincenzo; Foltran, Luisa; Nicolini, Mario; Biondi, Edoardo; Bramati, Annalisa; Turci, Daniele; Lazzarelli, Silvia; Verusio, Claudio; Bergamo, Francesca; Sobrero, Alberto; Frontini, Luciano; Magnani, Mauro
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
2018 Wong, Gabrielle S; Zhou, Jin; Bin Liu, Jie; Wu, Zhong; Xu, Xinsen; Li, Tianxia; Xu, David; Schumacher, Steven E; Puschhof, Jens; Mcfarland, James; Zou, Charles; Dulak, Austin; Henderson, Les; Xu, Peng; O'Day, Emily; Rendak, Rachel; Liao, Wei-Li; Cecchi, Fabiola; Hembrough, Todd; Schwartz, Sarit; Szeto, Christopher; Rustgi, Anil K; Wong, Kwok-Kin; Diehl, J Alan; Jensen, Karin; Graziano, Francesco; Ruzzo, Annamaria; Fereshetian, Shaunt; Mertins, Philipp; Carr, Steven A; Beroukhim, Rameen; Nakamura, Kenichi; Oki, Eiji; Watanabe, Masayuki; Baba, Hideo; Imamura, Yu; Catenacci, Daniel; Bass, Adam J
BRAF mutations and EGFR Intron-1 L/L genotype are associated with resistance to cetuximab plus irinotecan treatment in KRAS wild-type metastatic colorectal cancer patients
2008 Loupakis, F; Fornaro, L; Graziano, F; Santini, D; Cremolini, C; Stasi, I; Baldi, Gg; Salvatore, L; Vasile, E; Masi, G; Cupini, S; Canestrari, E; Ruzzo, Annamaria; Vincenzi, B; Tonini, G; Magnani, Mauro; Falcone, A.
BRAF V600E MUTATION AND AMPHIREGULIN (AR) IMMUNOHISTOCHEMICAL EXPRESSION IN THE PREDICTION OF BENEFIT FROM CETUXIMAB PLUS IRINOTECAN IN KRAS WILD-TYPE METASTATIC COLORECTAL CANCER (mCRC) PATIENTS
2009 Cremolini, C; Loupakis, F; Perrone, G; Ruzzo, Annamaria; Rulli, E; Garavaglia, D; Bencardino, K; Fornaro, L; Vincenzi, B; Stasi, I; Masi, G; Baldi, G; Floriani, I; Graziano, F; Falcone, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2196 Polymorphisms and miRNAs targeting CLOCK gene affect gender-related survival in metastatic colorectal cancer (mCRC) patients (pts) | 1-gen-2015 | Torsello, A.; Ruzzo, Annamaria; Sperduti, I.; Melucci, E.; Giacomini, E.; Mottolese, M.; Fiorino, R.; Zeuli, M.; Pescarmona, E.; Magnani, Mauro; Cognetti, F.; Garufi, C. | |
| 2206P Detection of circulating KRAS4A and KRAS4B isoforms in patients with metastatic lung adenocarcinoma treated with pembrolizumab or chemotherapy plus pembrolizumab by liquid biopsy: Clinical impact and association with circulating PD-L1 | 1-gen-2023 | Palladino, S.; Ruzzo, A.; Emili, R.; Catalano, V.; De Lisa, M.; Sarti, D.; Magnani, M.; Graziano, F.; Chiari, R. | |
| [Construction of an apparatus for pulsed field electrophoresis for the analysisof high molecular weight DNA] | 1-gen-1989 | Gennarelli, M; Novelli, G; Ruzzo, Annamaria; Grianti, F; Dallapiccola, B. | |
| A novel diffuse gastric cancer susceptibility variant in E-caderin(CDH1) intron 2: A case control study in an Italian population | 1-gen-2008 | Nasri, S; More, H; Graziano, F; Ruzzo, Annamaria; Wilson, E; Dunbier, A; Mckinney, C; Merriman, T; Guilford, P; Magnani, Mauro; Humar, B. | |
| A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4 | 1-gen-2020 | Campopiano, Rosa; Ferese, Rosangela; Buttari, Fabio; Femiano, Cinzia; Centonze, Diego; Fornai, Francesco; Biagioni, Francesca; Chiaravalloti, Maria Antonietta; Magnani, Mauro; Giardina, Emiliano; Ruzzo, Anna; Gambardella, Stefano | |
| A pharmacogenetic study for clinical outcomes of high-risk stage II and stage III colon cancer patients Treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy | 1-gen-2017 | Ruzzo, Annamaria; Galli, Fabio; Galli, Francesca; Rulli, E; Bagaloni, Irene; Lonardi, S; Bergamo, F; Ronzoni, M; Ionta, Mt; Massidda, B; Pella, N; Mucciarini, C; Labianca, R; Veltri, E; Sozzi, P; Barni, S; Nicolini, M; Biondi, E; Bramati, A; Turci, D; Buscaglia, M; Magnani, Mauro; Graziano, F. | |
| Amphiregulin (AR) expression in the prediction of benefit from cetuximab plus irinotecan in KRAS wild-type metastatic colorectal cancer (mCRC) patients | 1-gen-2009 | Loupakis, F; Cremolini, C; Perrone, G; Stasi, I; Salvatore, L; Vincenzi, B; Ruzzo, Annamaria; Ronzoni, M; Bencardino, K; Falcone, A. | |
| Amplificazione enzimatica specifica di una regione di DNA strettamente associata alla Corea di Huntington | 1-gen-1990 | Novelli, G; Mandich, P; Ruzzo, Annamaria; Mannello, Ferdinando; Ajmar, F; Dallapiccola, B. | |
| An erythroid-specific exon is present in the human hexokinase gene | 1-gen-1998 | Ruzzo, Annamaria; Andreoni, Francesca; Magnani, Mauro | |
| Analysis of polymorphisms in the Interleukin-1beta gene (IL-1B) and in the Interleukin-1 receptor anatagonist gene (IL-1RN) for gastric cancer susceptibility in Helicobacter Pylori (HP) negative, Italian patients. A report from the Italian Group for Genetic Research in Gastric Cancer (IGGRGC) | 1-gen-2004 | Ruzzo, Annamaria; Pizzagalli, F; Graziano, F; Santini, D; Catalano, V; Scartozzi, M; Ficarelli, R; Bearzl, I; Cascinu, S; Magnani, Mauro | |
| ANALYSIS OF PTEN EXPRESSION AND KRAS MUTATIONS ON PRIMARIES (PRIM) AND METASTASES (METS) TO PREDICT BENEFIT FROM CETUXIMAB PLUS IRINOTECAN (CETIRI) IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS) | 1-gen-2008 | Loupakis, F; Pollina, L; Ruzzo, Annamaria; Masi, G; Cremolini, C; Scartozzi, M; Floriani, I; Santini, D; Cascinu, S; Falcone, A. | |
| Assignment of the hexokinase type 3 gene (HK3) to human chromosome band 5q35.3 by somatic cell hybrids and in situ hybridization | 1-gen-1996 | Colosimo, A; Calabrese, G; Gennarelli, M; Ruzzo, Annamaria; Sangiuolo, F; Magnani, Mauro; Palka, G; Novelli, G; Dallapiccola, B. | |
| Association of BRAF mutations and EGFR Intron-1 L/L genotype with resistance to cetuximab plus irinotecan treatment in KRAS wild-type metastatic colorectal cancer patients | 1-gen-2009 | Ruzzo, Annamaria; Cremolini, C; Loupakis, F; Fornaro, L; Santini, D; Vincenzi, B; Canestrari, E; Magnani, Mauro; Falcone, A; Graziano, F. | |
| Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer | 1-gen-2002 | Humar, B; Graziano, F; Cascinu, S; Catalano, V; Ruzzo, Annamaria; Magnani, Mauro; Toro, T; Burchill, T; Futschik, Me; Merriman, T; Guilford, P. | |
| Association of Thymidylate Synthase Polymorphisms with Gastric Cancer Susceptibility | 1-gen-2004 | Graziano, F; Kawakami, K; Watanabe, G; Ruzzo, Annamaria; Humar, B; Santini, D; Catalano, V; Ficarelli, R; Merriman, T; Panunzi, S; Testa, E; Cascinu, S; Bearzi, I; Tonini, G; Magnani, Mauro | |
| ASSOCIATION OF THYMIDYLATHE SYNTHASE POLYMORPHISMS WITH GASTRIC CANCER SUSCEPTIBILITY | 1-gen-2004 | Graziano, F; Kawakami, K; Watanabe, G; Ruzzo, Annamaria; Santini, D; Catalano, V; Ficarelli, R; Humar, B; Merriman, T; Guilford, P; Testa, E; Galizia, E; Magnani, Mauro; Cascinu, S. | |
| Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy | 1-gen-2020 | Ruzzo, Annamaria; Graziano, Francesco; Galli, Francesca; Galli, Fabio; Rulli, Eliana; Lonardi, Sara; Ronzoni, Monica; Massidda, Bruno; Zagonel, Vittorina; Pella, Nicoletta; Mucciarini, Claudia; Labianca, Roberto; Teresa Ionta, Maria; Bagaloni, Irene; Veltri, Enzo; Sozzi, Pietro; Barni, Sandro; Ricci, Vincenzo; Foltran, Luisa; Nicolini, Mario; Biondi, Edoardo; Bramati, Annalisa; Turci, Daniele; Lazzarelli, Silvia; Verusio, Claudio; Bergamo, Francesca; Sobrero, Alberto; Frontini, Luciano; Magnani, Mauro | |
| Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition | 1-gen-2018 | Wong, Gabrielle S; Zhou, Jin; Bin Liu, Jie; Wu, Zhong; Xu, Xinsen; Li, Tianxia; Xu, David; Schumacher, Steven E; Puschhof, Jens; Mcfarland, James; Zou, Charles; Dulak, Austin; Henderson, Les; Xu, Peng; O'Day, Emily; Rendak, Rachel; Liao, Wei-Li; Cecchi, Fabiola; Hembrough, Todd; Schwartz, Sarit; Szeto, Christopher; Rustgi, Anil K; Wong, Kwok-Kin; Diehl, J Alan; Jensen, Karin; Graziano, Francesco; Ruzzo, Annamaria; Fereshetian, Shaunt; Mertins, Philipp; Carr, Steven A; Beroukhim, Rameen; Nakamura, Kenichi; Oki, Eiji; Watanabe, Masayuki; Baba, Hideo; Imamura, Yu; Catenacci, Daniel; Bass, Adam J | |
| BRAF mutations and EGFR Intron-1 L/L genotype are associated with resistance to cetuximab plus irinotecan treatment in KRAS wild-type metastatic colorectal cancer patients | 1-gen-2008 | Loupakis, F; Fornaro, L; Graziano, F; Santini, D; Cremolini, C; Stasi, I; Baldi, Gg; Salvatore, L; Vasile, E; Masi, G; Cupini, S; Canestrari, E; Ruzzo, Annamaria; Vincenzi, B; Tonini, G; Magnani, Mauro; Falcone, A. | |
| BRAF V600E MUTATION AND AMPHIREGULIN (AR) IMMUNOHISTOCHEMICAL EXPRESSION IN THE PREDICTION OF BENEFIT FROM CETUXIMAB PLUS IRINOTECAN IN KRAS WILD-TYPE METASTATIC COLORECTAL CANCER (mCRC) PATIENTS | 1-gen-2009 | Cremolini, C; Loupakis, F; Perrone, G; Ruzzo, Annamaria; Rulli, E; Garavaglia, D; Bencardino, K; Fornaro, L; Vincenzi, B; Stasi, I; Masi, G; Baldi, G; Floriani, I; Graziano, F; Falcone, A. |